Novo Nordisk A/S (NVO)
132.85
+0.44
(+0.33%)
USD |
NYSE |
May 14, 15:25
Novo Nordisk Price: 132.85 for May 14, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 13, 2024 | 131.47 | 133.50 | 130.40 | 132.41 | 5.914M |
May 10, 2024 | 129.09 | 130.27 | 128.33 | 128.42 | 3.081M |
May 09, 2024 | 127.44 | 128.80 | 126.94 | 128.66 | 2.374M |
May 08, 2024 | 127.51 | 128.43 | 126.62 | 126.69 | 4.060M |
May 07, 2024 | 126.65 | 127.80 | 126.38 | 127.29 | 4.167M |
May 06, 2024 | 122.00 | 124.64 | 121.78 | 124.59 | 3.637M |
May 03, 2024 | 122.92 | 123.77 | 121.29 | 123.05 | 5.933M |
May 02, 2024 | 127.94 | 127.94 | 123.83 | 124.02 | 8.487M |
May 01, 2024 | 127.80 | 130.13 | 127.50 | 129.21 | 5.218M |
Apr 30, 2024 | 128.05 | 130.46 | 127.49 | 128.31 | 7.841M |
Apr 29, 2024 | 127.32 | 127.97 | 126.52 | 126.88 | 2.111M |
Apr 26, 2024 | 126.15 | 127.90 | 125.99 | 126.85 | 3.312M |
Apr 25, 2024 | 123.69 | 125.85 | 123.21 | 125.79 | 3.434M |
Apr 24, 2024 | 127.16 | 127.32 | 125.35 | 126.16 | 3.143M |
Apr 23, 2024 | 126.57 | 128.76 | 126.34 | 128.64 | 3.704M |
Apr 22, 2024 | 122.59 | 126.25 | 122.57 | 125.26 | 3.798M |
Apr 19, 2024 | 123.48 | 124.54 | 122.46 | 122.71 | 5.183M |
Apr 18, 2024 | 123.30 | 124.10 | 122.51 | 122.75 | 2.841M |
Apr 17, 2024 | 124.95 | 125.21 | 123.26 | 124.53 | 3.075M |
Apr 16, 2024 | 123.07 | 124.25 | 121.79 | 123.45 | 3.044M |
Apr 15, 2024 | 125.81 | 126.05 | 123.52 | 123.90 | 2.897M |
Apr 12, 2024 | 126.74 | 127.06 | 124.35 | 124.51 | 3.343M |
Apr 11, 2024 | 125.48 | 125.88 | 124.13 | 125.40 | 2.419M |
Apr 10, 2024 | 123.39 | 125.26 | 123.24 | 124.93 | 3.025M |
Apr 09, 2024 | 126.18 | 126.74 | 124.22 | 124.86 | 3.215M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
23.40
Minimum
May 16 2019
135.92
Maximum
Mar 07 2024
55.45
Average
50.73
Median
Price Benchmarks
Amgen Inc | 312.32 |
AstraZeneca PLC | 77.25 |
GSK PLC | 45.58 |
Viking Therapeutics Inc | 72.61 |
Evaxion Biotech AS | 3.72 |
Price Related Metrics
PE Ratio | 45.86 |
PS Ratio | 16.76 |
PEG Ratio | 0.8682 |
Price to Book Value | 41.36 |
Price to Free Cash Flow | 81.27 |
Earnings Yield | 2.18% |
Market Cap | 591.83B |
PEGY Ratio | 0.8515 |
Operating PE Ratio | 37.41 |
Normalized PE Ratio | 45.86 |